BRPI0410237A - metil indóis e metil pirrolopiridinas como agonistas adrenérgicos alfa-1 - Google Patents

metil indóis e metil pirrolopiridinas como agonistas adrenérgicos alfa-1

Info

Publication number
BRPI0410237A
BRPI0410237A BRPI0410237-1A BRPI0410237A BRPI0410237A BR PI0410237 A BRPI0410237 A BR PI0410237A BR PI0410237 A BRPI0410237 A BR PI0410237A BR PI0410237 A BRPI0410237 A BR PI0410237A
Authority
BR
Brazil
Prior art keywords
sup
methyl
alpha
pyrrolopyridines
adrenergic agonists
Prior art date
Application number
BRPI0410237-1A
Other languages
English (en)
Inventor
Michael Patrick Dillon
Clara Jeou Jen Lin
Amy Geraldine Moore
Counde O'yang
Yansheng Zhai
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0410237A publication Critical patent/BRPI0410237A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

"METIL INDóIS E METIL PIRROLOPIRIDINAS COMO AGONISTAS ADRENéRGICOS ALFA-1". A presente invenção refere-se a compostos que são agonistas receptor alfa-1, de preferência agonistas receptor alfa -1 A/L, e que são representados pela formula (I), onde m, A, X, Y, R¬ 1¬, R¬ 2¬, R¬ 3¬, R¬ 4¬ e R¬ 5¬ são conforme definidos neste pedido de patente; ou isómeros individuais, misturas racêmicas ou não-racêmicas de isómeros, ou seus sais ou solvatos farmaceuticamente aceitáveis. A invenção ainda refere-se a composições farmacêuticas contendo tais compostos, a métodos para seu uso como agentes terapêuticos, e a métodos de preparação deles.
BRPI0410237-1A 2003-05-09 2004-04-30 metil indóis e metil pirrolopiridinas como agonistas adrenérgicos alfa-1 BRPI0410237A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46925503P 2003-05-09 2003-05-09
PCT/EP2004/004609 WO2004099189A1 (en) 2003-05-09 2004-04-30 Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists

Publications (1)

Publication Number Publication Date
BRPI0410237A true BRPI0410237A (pt) 2006-05-09

Family

ID=33435226

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410237-1A BRPI0410237A (pt) 2003-05-09 2004-04-30 metil indóis e metil pirrolopiridinas como agonistas adrenérgicos alfa-1

Country Status (15)

Country Link
US (1) US6979696B2 (pt)
EP (1) EP1660484B1 (pt)
JP (1) JP4454622B2 (pt)
KR (1) KR100751163B1 (pt)
CN (1) CN100378097C (pt)
AT (1) ATE406363T1 (pt)
AU (1) AU2004235923B2 (pt)
BR (1) BRPI0410237A (pt)
CA (1) CA2523253C (pt)
DE (1) DE602004016177D1 (pt)
ES (1) ES2313019T3 (pt)
MX (1) MXPA05011841A (pt)
PL (1) PL1660484T3 (pt)
RU (1) RU2313524C2 (pt)
WO (1) WO2004099189A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05004929A (es) * 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
TW200602317A (en) * 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
CA2624220A1 (en) * 2005-09-29 2007-04-12 Wyeth 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
JP2009517432A (ja) * 2005-11-30 2009-04-30 エフ．ホフマン−ラ ロシュ アーゲー ３−アミノ−２−アリールプロピルアザインドールおよびその使用
LT2658844T (lt) 2010-12-28 2017-02-10 Sanofi Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių
CN102702196B (zh) * 2012-06-13 2015-01-14 南京药石药物研发有限公司 3-甲基-7-氮杂吲哚的合成方法
KR102129842B1 (ko) * 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
WO2016014426A1 (en) * 2014-07-21 2016-01-28 The Arizona Board Of Regents Organic reactions
JP7688785B2 (ja) * 2022-10-14 2025-06-04 株式会社三和化学研究所 イミダゾール誘導体
WO2024254218A2 (en) * 2023-06-05 2024-12-12 The Board Of Regents Of The University Of Texas System Non-peptide small molecule fgf14:nav1.6 channel complex protein-protein interaction modulators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370063A (en) * 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US3586695A (en) * 1968-01-26 1971-06-22 Dow Chemical Co Substituted imidazolinyl indoles
GB9011335D0 (en) 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5767133A (en) 1993-06-14 1998-06-16 Pfizer Inc. Secondary amines as antidiabetic and antiobesity agents
JPH0887346A (ja) * 1994-09-14 1996-04-02 Chino Kogyo:Kk パソコン等デスク上を活用する為の卓上台座器具
EA199900375A1 (ru) 1996-11-14 1999-12-29 Пфайзер Инк. Способ получения замещенных пиридинов
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
GB9910110D0 (en) * 1999-04-30 1999-06-30 Glaxo Group Ltd Chemical compounds
CA2403806A1 (en) 2000-03-23 2002-09-20 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
DE10106214A1 (de) * 2001-02-10 2002-08-14 Boehringer Ingelheim Pharma Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
EP1501826B1 (en) * 2002-02-01 2006-09-27 F. Hoffman-la Roche AG Substituted indoles as alpha-1 agonists

Also Published As

Publication number Publication date
CN100378097C (zh) 2008-04-02
ATE406363T1 (de) 2008-09-15
US20040224973A1 (en) 2004-11-11
CA2523253A1 (en) 2004-11-18
RU2005138143A (ru) 2006-08-10
KR20060015590A (ko) 2006-02-17
KR100751163B1 (ko) 2007-08-22
DE602004016177D1 (de) 2008-10-09
RU2313524C2 (ru) 2007-12-27
ES2313019T3 (es) 2009-03-01
CA2523253C (en) 2010-06-22
WO2004099189A1 (en) 2004-11-18
MXPA05011841A (es) 2006-01-26
PL1660484T3 (pl) 2009-02-27
EP1660484B1 (en) 2008-08-27
JP2006525970A (ja) 2006-11-16
JP4454622B2 (ja) 2010-04-21
EP1660484A1 (en) 2006-05-31
AU2004235923B2 (en) 2008-01-24
AU2004235923A1 (en) 2004-11-18
US6979696B2 (en) 2005-12-27
CN1784397A (zh) 2006-06-07

Similar Documents

Publication Publication Date Title
PL361361A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
PL361282A1 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
MXPA05011710A (es) Derivados de pirimidina con actividad de crf.
UY28026A1 (es) 4-piperazinilbencenosulfonilindoles y usos de los mismos.
MY130803A (en) New quinuclidine amide derivatives
UY27336A1 (es) Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
UY27322A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
MXPA04000456A (es) Analogos de prostaglandina como agonistas del receptor ep4.
MX2009006018A (es) Derivados de quinuclidinol como antagonistas de receptores muscarinicos.
SI1506185T1 (sl) Spojine in njihova uporaba kot inhibitorji 5-HT
YU53100A (sh) Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
ATE417838T1 (de) Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PL374019A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
DE602006005685D1 (de) Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-liganden
MXPA04005076A (es) Derivados de 4-piperidinil alquilamina como antagonistas del receptor muscarinico.
PL1660484T3 (pl) Metyloindole i metylopirolopirydyny jako agoniści receptora adrenergicznego α-1
MXPA04005313A (es) Derivados de aminotetralin como antagonistas del receptor muscarinico.
BRPI0519709A2 (pt) derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MXPA05011476A (es) Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2.
SE0403118D0 (sv) New compounds 2

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.